全部所有文章
-
聯生藥抗體新藥UB-421皮下注射(SC)劑型 獲台灣衛福部核准進行臨床I期試驗
聯生藥抗體新藥UB-421皮下注射(SC)劑型 獲台灣衛福部核准進行臨床I期試驗聯生藥抗體新藥UB-421皮下注射(SC)劑型 獲台灣衛福部核准進行臨床I期試驗more -
聯亞集團董事長特助彭文君博士向社會大眾報告UBI /聯亞生技集團新冠肺炎研發進度。
聯亞集團董事長特助彭文君博士向社會大眾報告UBI /聯亞生技集團新冠肺炎研發進度。聯亞集團董事長特助彭文君博士向社會大眾報告UBI /聯亞生技集團新冠肺炎研發進度。more -
Remarks by President Trump at Signing of Executive Orders on Lowering Drug Prices | The White House
Remarks by President Trump at Signing of Executive Orders on Lowering Drug PricesRemarks by President Trump at Signing of Executive Orders on Lowering Drug Prices | The White Housemore -
UBI/聯亞集團高精準設計新冠肺炎(COVID-19) 疫苗UB-612將於今年第三季展開第一期人體臨床試驗，TFDA 與CDE已派員進行駐廠監製
UBI/聯亞集團高精準設計新冠肺炎(COVID-19) 疫苗UB-612將於今年第三季展開第一期人體臨床試驗，TFDA 與CDE已派員進行駐廠監製UBI/聯亞集團高精準設計新冠肺炎(COVID-19) 疫苗UB-612將於今年第三季展開第一期人體臨床試驗，TFDA 與CDE已派員進行駐廠監製more -
Dr. Flossie Wong-Staal, a board member of UBI since 1995, passed away on Wednesday, July 8th, at the age of 73 due to pneumonia
Dr. Flossie Wong-Staal, a board member of UBI since 1995, passed away on Wednesday, July 8th, at the age of 73 due to pneumoniaDr. Flossie Wong-Staal, a board member of UBI since 1995, passed away on Wednesday, July 8th, at the age of 73 due to pneumoniamore -
陳時中率領防疫團隊視察UBI/聯亞集團，新冠疫苗研發生產一條龍，盼年底進入人體臨床試驗
陳時中率領防疫團隊視察UBI/聯亞集團，新冠疫苗研發生產一條龍，盼年底進入人體臨床試驗陳時中率領防疫團隊視察UBI/聯亞集團，新冠疫苗研發生產一條龍，盼年底進入人體臨床試驗more -
News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine
As they race to devise a vaccine, researchers are trying to ensure that their candidates don’t spur a counterproductive, even dangerous, immune system reaction known as immune enhancement.News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccinemore -
United BioPharma Received Approval from TFDA for a Phase 3 Trial with UB-421 in Patients with Multi-Drug Resistance (MDR) HIV-1 infection
United BioPharma Received Approval from TFDA for a Phase 3 Trial with UB-421 in Patients with Multi-Drug Resistance (MDR) HIV-1 infectionUnited BioPharma Received Approval from TFDA for a Phase 3 Trial with UB-421 in Patients with Multi-Drug Resistance (MDR) HIV-1 infectionmore -
聯生藥抗體新藥UB-421用於多重抗藥性愛滋病患3期臨床試驗獲台灣FDA核准執行
聯生藥抗體新藥UB-421用於多重抗藥性愛滋病患3期臨床試驗獲台灣FDA核准執行聯生藥抗體新藥UB-421用於多重抗藥性愛滋病患3期臨床試驗獲台灣FDA核准執行more
